Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines

January 06, 2022   |   January 2022 Bond Updates
SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, today announced an agreement with Sino Health Pharmaceutical Limited ("Sino Health") , an...

View more at: https://www.prnewswire.com:443/news-releases/nuance-pharma-acquires-sino-health-to-further-strengthen-its-commercial-capabilities-and-expand-pipelines-301455282.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/